Your session is about to expire
← Back to Search
Static Magnetic Fields for Peripheral Vascular Disease
Study Summary
This trial will test if static magnetic fields can affect blood flow and pulses in the arm.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any known heart conditions.I do not have any known nerve or brain problems.I cannot or do not want to stay still for about 55 minutes.I have been diagnosed with diabetes.I am between 18 and 35 years old.You have any metal or wire implants in your body.
- Group 1: Healthy Adults-magnet
- Group 2: Healthy Adults-sham
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the qualifications for participation in this research study?
"To fulfill the criteria for this medical trial, applicants must possess peripheral arterial disease and be aged 18 to 35. A total of 60 individuals are necessary to complete the study's objectives."
Is this trial enrolling geriatric individuals?
"This clinical trial is open to people aged between 18 and 35. For younger patients, there are 12 trials available, while those over 65 can access 217 different studies."
Are there still openings for enrolment in this research project?
"Affirmative. Per the information on clinicaltrials.gov, this trial has been actively recruiting since its inauguration on November 1st 2022 and is presently in search of 60 participants from one medical centre."
What is the limit of participants in this research?
"Affirmative. The registry on clinicaltrials.gov reveals that, after being posted in November 2022 and edited last month, this trial is actively enrolling 60 patients at a single site."
Share this study with friends
Copy Link
Messenger